Manuel Ochoa

736 total citations
22 papers, 606 citations indexed

About

Manuel Ochoa is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Manuel Ochoa has authored 22 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Manuel Ochoa's work include Nitric Oxide and Endothelin Effects (11 papers), Heart Rate Variability and Autonomic Control (6 papers) and Cardiac Imaging and Diagnostics (4 papers). Manuel Ochoa is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Heart Rate Variability and Autonomic Control (6 papers) and Cardiac Imaging and Diagnostics (4 papers). Manuel Ochoa collaborates with scholars based in United States. Manuel Ochoa's co-authors include Thomas H. Hintze, Xiaobin Xu, Gong Zhao, I. Bernard Weinstein, Carl I. Thompson, Traci Vogel, Paul R. Forfia, Luiz Belardinelli, Sarra Laycock and Fabio A. Recchia and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Manuel Ochoa

22 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuel Ochoa United States	13	292	238	161	107	74	22	606
G. Fleckenstein‐Grün Germany	16	328 1.1×	153 0.6×	229 1.4×	82 0.8×	56 0.8×	43	731
Ann F.C. Roberts United Kingdom	8	153 0.5×	85 0.4×	105 0.7×	70 0.7×	113 1.5×	12	435
D. J. Paulson United States	15	303 1.0×	218 0.9×	397 2.5×	62 0.6×	149 2.0×	23	907
M. Frey Germany	13	244 0.8×	118 0.5×	143 0.9×	73 0.7×	47 0.6×	34	546
Miki Asano Japan	18	301 1.0×	267 1.1×	410 2.5×	75 0.7×	48 0.6×	72	978
Morgan He United States	11	276 0.9×	206 0.9×	334 2.1×	109 1.0×	191 2.6×	18	792
V. I. Kapelko Russia	16	330 1.1×	127 0.5×	260 1.6×	135 1.3×	181 2.4×	69	812
M. Ochoa United States	11	305 1.0×	297 1.2×	107 0.7×	35 0.3×	73 1.0×	15	552
Mariagnes Verosky United States	15	150 0.5×	220 0.9×	334 2.1×	27 0.3×	54 0.7×	51	777
J. S. Ingwall United States	13	513 1.8×	154 0.6×	371 2.3×	250 2.3×	169 2.3×	20	958

Countries citing papers authored by Manuel Ochoa

Since Specialization

Citations

This map shows the geographic impact of Manuel Ochoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Ochoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Ochoa more than expected).

Fields of papers citing papers by Manuel Ochoa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Ochoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Ochoa. The network helps show where Manuel Ochoa may publish in the future.

Co-authorship network of co-authors of Manuel Ochoa

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Ochoa. A scholar is included among the top collaborators of Manuel Ochoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Ochoa. Manuel Ochoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Gong, Suhua Zhang, John C. Shryock, et al.. (2011). Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogs. Journal of Nuclear Cardiology. 19(1). 109–117. 3 indexed citations

Zhao, Gong, John C. Shryock, E. J. Messina, et al.. (2011). Antiadrenergic and Hemodynamic Effects of Ranolazine in Conscious Dogs. Journal of Cardiovascular Pharmacology. 57(6). 639–647. 33 indexed citations

Zhao, Gong, John C. Shryock, E. J. Messina, et al.. (2008). Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs. Journal of Cardiovascular Pharmacology. 52(5). 467–473. 9 indexed citations

Zhao, Gong, E. J. Messina, Xiaobin Xu, et al.. (2007). Caffeine Attenuates the Duration of Coronary Vasodilation and Changes in Hemodynamics Induced by Regadenoson (CVT-3146), a Novel Adenosine A2A Receptor Agonist. Journal of Cardiovascular Pharmacology. 49(6). 369–375. 22 indexed citations

Zhao, Gong, E. J. Messina, Xiaobin Xu, et al.. (2006). Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs. European Journal of Pharmacology. 541(3). 171–176. 5 indexed citations

Zhao, Gong, Axel Linke, Xiaobin Xu, et al.. (2003). Comparison of vasodilation by CVT-3146, a novel A2Areceptor agonist, and adenosine in different vascular beds in awake dogs. Journal of the American College of Cardiology. 41(6). 312–312. 1 indexed citations

Zhao, Gong, Axel Linke, Xiaobin Xu, et al.. (2003). Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs. Journal of Pharmacology and Experimental Therapeutics. 307(1). 182–189. 53 indexed citations

Kinugawa, Shintaro, Heiner Post, Pawel M. Kaminski, et al.. (2003). Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes. Circulation. 108(23). 2934–2940. 41 indexed citations

Osorio, Juan C., Xiaobin Xu, Traci Vogel, et al.. (2001). Plasma Nitrate Accumulation during the Development of Pacing-Induced Dilated Cardiac Myopathy in Conscious Dogs Is Due to Renal Impairment. Nitric Oxide. 5(1). 7–17. 8 indexed citations

10.

Loke, Kit E., Paul R. Forfia, Fabio A. Recchia, et al.. (2000). Bovine Polymerized Hemoglobin Increases Cardiac Oxygen Consumption and Alters Myocardial Substrate Metabolism in Conscious Dogs: Role of Nitric Oxide. Journal of Cardiovascular Pharmacology. 35(1). 84–92. 13 indexed citations

11.

Tada, Hideo, Carl I. Thompson, Fabio A. Recchia, et al.. (2000). Myocardial Glucose Uptake Is Regulated by Nitric Oxide via Endothelial Nitric Oxide Synthase in Langendorff Mouse Heart. Circulation Research. 86(3). 270–274. 69 indexed citations

12.

Zhao, Gong, Xiao–Ping Zhang, Carolyn J. Smith, et al.. (1999). Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. American Journal of Physiology-Heart and Circulatory Physiology. 277(1). H268–H278. 42 indexed citations

13.

Stewart, Julian M., Xiaobin Xu, Manuel Ochoa, & Thomas H. Hintze. (1998). Exercise reduces epicardial coronary artery wall stiffness: roles of cGMP and cAMP. Medicine & Science in Sports & Exercise. 30(2). 220–228. 5 indexed citations

14.

Laycock, Sarra, Traci Vogel, Paul R. Forfia, et al.. (1998). Role of Nitric Oxide in the Control of Renal Oxygen Consumption and the Regulation of Chemical Work in the Kidney. Circulation Research. 82(12). 1263–1271. 101 indexed citations

15.

Zhao, Gong, Xiao–Ping Zhang, Xiaobin Xu, Manuel Ochoa, & Thomas H. Hintze. (1997). Short-term Exercise Training Enhances Reflex Cholinergic Nitric Oxide–Dependent Coronary Vasodilation in Conscious Dogs. Circulation Research. 80(6). 868–876. 17 indexed citations

16.

Zhao, Gong, Weiqun Shen, Xiaobin Xu, et al.. (1995). Selective Impairment of Vagally Mediated, Nitric Oxide–Dependent Coronary Vasodilation in Conscious Dogs After Pacing-Induced Heart Failure. Circulation. 91(10). 2655–2663. 54 indexed citations

17.

Wang, Jie, Gong Zhao, Weiqun Shen, et al.. (1993). Effects of an Orally Active NO-Releasing Agent, CAS 936, and Its Active Metabolite, 3754, on Cardiac and Coronary Dynamics in Normal Conscious Dogs and After Pacing-Induced Heart Failure. Journal of Cardiovascular Pharmacology. 22(Suppl. 7). S51–S51. 12 indexed citations

18.

Weinstein, I. Bernard, Manuel Ochoa, & S. Marvin Friedman. (1966). Fidelity in the Translation of Messenger Ribonucleic Acids in Mammalian Subcellular Systems^*. Biochemistry. 5(10). 3332–3339. 38 indexed citations

19.

Ochoa, Manuel, Alfred Gellhorn, & William B. Benjamin. (1964). Phthalanilide Inhibition of Protein Synthesis in a Cell-free L1210 Mouse Ascites Leukemia System. Cancer Research. 24. 480–484. 12 indexed citations

20.

Ochoa, Manuel & I. Bernard Weinstein. (1964). Polypeptide Synthesis in a Subcellular System Derived from the L1210 Mouse Ascites Leukemia. Journal of Biological Chemistry. 239(11). 3834–3842. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact